Sort
23,748 grants matching “melanoma”
Studies of Human T Regulatory Cells
$970,827Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Vaccines and Therapeutics for Anthrax
$968,264Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Evolution of Primary and Resistant Solid Tumors
$968,176Ronald Anthony Depinho · Dana-Farber Cancer Inst · U01 · FY2008 · CA
Biology and genetics of metastatic disease
$966,151Sohail F. Tavazoie · Rockefeller University · R35 · FY2024 · CA
Reprogramming of T cells for the Treatment of Melanoma
$965,794Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Epigenetic Alterations Induced by Tobacco Smoke
$965,749David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$965,587Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$965,424Mark Reid Philips · New York University School Of Medicine · R35 · FY2024 · CA
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$965,409Myriam Gorospe · National Institute On Aging · ZIA · FY2017 · AG
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$964,392William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Comparative Biomedical Scientist Training Program
$963,134Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2015 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$962,665Mark Reid Philips · New York University School Of Medicine · R35 · FY2023 · CA
Characterization and improvement of graft versus leukemia effects
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
DCTD Human Toxicology and Pharmacology
$962,236David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Vanderbilt Clinical Oncology Research Career Development Award
$961,183Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2018 · CA
Quantitative stepwise analysis of RNA interference
$960,934Sua Myong · University Of Illinois At Urbana-Champaign · DP2 · FY2012 · GM
Riluzole Prodrugs for Melanoma and ALS
$960,120Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R44 · FY2013 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Riluzole Prodrugs for Melanoma and ALS
$959,604Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$959,375H-H. Sherry Chow · University Of Arizona · UG1 · FY2019 · CA
NIA/RRB Confocal Imaging Facility
$959,160Fred Indig · National Institute On Aging · ZIC · FY2009 · AG
Evolution of Primary and Resistant Solid Tumors
$958,557Dana-Farber Cancer Institute · U01 · FY2005 · CA
Functional genomic analysis of neural crest development
$958,484William J Pavan · National Human Genome Research Institute · ZIA · FY2019 · HG